“We are pleased to partner with Prevencio to provide actionable data to battle heart disease, the number one cause of death in our nation. With more than 15 million US heart disease patients, and tens of millions of additional patients at risk, there is a clear unmet need for highly accurate, AI-based, multi-protein blood tests.”
Dr. Michael Kalnoski, Atlas Genomics’ CEO and Chief Medical Officer
“Atlas Genomics has provided extraordinary quality, service and turnaround times to extend and complement our own internal resources. Partnering with them is seamless, and they have become an extension of our team. Their attention to detail and ability to collaborate allows us the freedom to expand our capabilities and deliver high quality results under very difficult time pressure.”
Head of Non-Clinical Services, Top 10 Pharmaceutical Company
“Diagnostic Cytogenetics, Inc. does outstanding work. They are extremely fast, with cytogenetics results often being available at the time of our primary case signout. DCI reports are concise, easy to read, and coherent. Most importantly, I have complete confidence in the results. Overall, we have been delighted with the work done by DCI.”
Gregory Wolgamot, MD PhD. Pathologist at Northwest Pathology